openPR Logo
Press release

Cholestasis Market Expected to Rise Steadily throughout 2016 - 2024

04-16-2018 07:16 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Cholestasis Market Expected to Rise Steadily throughout 2016 -

Cholestasis is a condition (not a disease) where bile cannot flow from the liver to the duodenum. The two basic distinctions are an obstructive type of cholestasis where there is a mechanical blockage in the duct system that can occur from agallstone or malignancy, and metabolic types of cholestasis which are disturbances in bile formation that can occur because of genetic defects or acquired as a side effect of many medications. Based on the defect location, cholestasis can be segmented as extrahepatic cholestasis and intrahepatic cholestasis.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14981

Cholestasis market: Symptoms

Itchiness is the primary symptom of cholestasis and is thought to be due to interactions of serum bile acids with opioidergic nerves. In fact, the opioid antagonist naltrexone is used to treat itchiness due to cholestasis. Although jaundice is an uncommon occurrence in intrahepatic (metabolic) cholestasis, but is common in obstructive cholestasis. Pale stool and dark urine are the other symptoms of obstructive cholestasis.

Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=14981

Cholestasis market: Causes

Bile duct tumors, pancreatitis, stones in the common bile duct, pseudocyst or pancreatic tumor, pancreatic cysts and primary sclerosing cholangitis are some of the major causes for extrahepatic cholestasis.Intrahepatic cholestasis is usually caused by hepatitis or by medications that can produce symptoms resemblinghepatitis. Intrahepatic cholestasis is also caused due to amyloidosis, bacterial abscess in the liver, lymphoma, alcoholic liver disease, pregnancy, primary sclerosing cholangitis, tuberculosis (TB), viral hepatitis and sarcoidosis. Sometimes, certain medications also result in cholestasis that include anabolic steroids, tolbutamide, prochlorperazine, estradio, terbinafine, imipramine, chlorpromazine, birth control pills and cimetidine. Cholestasis occurs in about one out of thousand pregnancies but is more common in Swedish and Chilean ethnic groups.

View Report: https://www.transparencymarketresearch.com/cholestasis-market.html

Cholestasis market: Diagnosis

Cholestasis can be diagnosed through CT scan, MRI scan, ultrasound and endoscopic retrograde cholangiopancreatography. Blood test will also enable physicians to determine the volume of bilirubin, and alkaline phosphatase and hence will be able to diagnose cholestasis. Cholestasis often do not respond to medical therapy, however, ursodeoxycholic acid has proven its success in increasing the secretion of bile in children to cure the disease. Liver transplantation is also performed to treat cholestasis. The market for cholestasis will grow owing to rising incidences of various diseases such as cancer, TB and lymphoma. The World Health Organization (WHO) has estimated that approximately 1.5 million people died of 9.6 million people who suffered from tuberculosis (TB) worldwide in 2014. Similarly, changing lifestyle has altered dietary pattern that will also propel the growth of this market. The major players of the market include Eli Lily and Company, Abbott Laboratories, Asklepion Pharmaceuticals, LLC and Palmetto Health among other significant players.

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cholestasis Market Expected to Rise Steadily throughout 2016 - 2024 here

News-ID: 1016883 • Views:

More Releases from Transparency Market Research

RAS-acting Agents Market Size Will Expected to Surpass US$ 13.4 Billion [by 2031], Growing at 4.2% CAGR - Transparency Market Research Inc.
RAS-acting Agents Market Size Will Expected to Surpass US$ 13.4 Billion [by 2031 …
RAS-acting agents play a crucial role in managing hypertension and cardiovascular diseases by targeting the renin-angiotensin system. These agents, including ACE inhibitors, angiotensin receptor blockers (ARBs), and direct renin inhibitors, are widely prescribed due to their proven efficacy and safety. The increasing prevalence of cardiovascular disorders, rising geriatric population, and growing awareness about hypertension management are key factors driving the expansion of the global RAS-acting agents market. The global RAS-acting agents
Chemical Sensors Market to Hit USD 40.1 Billion by the end of 2031, Transparency Market Research, Inc.
Chemical Sensors Market to Hit USD 40.1 Billion by the end of 2031, Transparency …
The chemical sensors market has witnessed significant growth in recent years, driven by advancements in sensor technology, increasing environmental concerns, and the rising demand for real-time monitoring systems. Chemical sensors are crucial for detecting and measuring chemical compounds in various applications, including industrial safety, healthcare, environmental monitoring, and defense. The Chemical Sensors Market is expected to reach a valuation of USD 40.1 billion by 2031. Additionally, the report forecasts a compound
Pore Strips Market Set to Expand at 5.8% CAGR, Driven by Rising Demand for Cost-Effective Skincare - Analysis by TMR
Pore Strips Market Set to Expand at 5.8% CAGR, Driven by Rising Demand for Cost- …
The global pore strips market, valued at $1.4 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2031, reaching $1.8 billion by the end of 2031. The increasing prevalence of blackheads, rising pollution levels, and the growing demand for cost-effective skincare treatments are key factors driving market expansion. Explore the highlights and essential data from our Report in this sample -
Smart Smoke Detectors Drive Market Growth at 6.4% CAGR, Projected to Reach $3.5 Billion by 2031 - Analysis by TMR
Smart Smoke Detectors Drive Market Growth at 6.4% CAGR, Projected to Reach $3.5 …
The global smoke detector market is poised for significant growth, driven by increasing safety regulations, rising awareness about fire hazards, and technological advancements in smoke detection systems. In 2022, the industry was valued at approximately US$ 2.0 billion and is projected to reach US$ 3.5 billion by 2031, advancing at a CAGR of 6.4% from 2023 to 2031. With fire accidents remaining a major concern in residential, commercial, and industrial

All 5 Releases


More Releases for Cholestasis

Growing prevalence of obstetric cholestasis to drive growth of the overall chole …
According to a report published in National Center for Biotechnology Information, Intrahepatic cholestasis of pregnancy (ICP) or obstetric cholestasis is the major liver disease during pregnancy. Obstetric cholestasis is characteristically a reversible disease typically occurring in the second to third trimester. It is characterized by pruritus (severe itching of the skin) mainly in the palms and soles, prominent serum aminotransferases coupled with increased serum bile acid levels. As the number
Cholestasis Market Value Chain Analysis and Forecast Up to 2024
Cholestasis is a condition (not a disease) where bile cannot flow from the liver to the duodenum. The two basic distinctions are an obstructive type of cholestasis where there is a mechanical blockage in the duct system that can occur from agallstone or malignancy, and metabolic types of cholestasis which are disturbances in bile formation that can occur because of genetic defects or acquired as a side effect of many
Cholestasis Market 2016 Share, Trend, Segmentation and Forecast to 2024
Cholestasis is a condition (not a disease) where bile cannot flow from the liver to the duodenum. The two basic distinctions are an obstructive type of cholestasis where there is a mechanical blockage in the duct system that can occur from agallstone or malignancy, and metabolic types of cholestasis which are disturbances in bile formation that can occur because of genetic defects or acquired as a side effect of many medications. Based on the defect location,
Cholestasis Market Will Reflect Significant Growth Prospects During 2016-2024
Cholestasis is a condition (not a disease) where bile cannot flow from the liver to the duodenum. The two basic distinctions are an obstructive type of cholestasis where there is a mechanical blockage in the duct system that can occur from agallstone or malignancy, and metabolic types of cholestasis which are disturbances in bile formation that can occur because of genetic defects or acquired as a side effect of many
Cholestasis Treatment Market - Global Industry Analysis 2024
The liver plays a pivotal role in control of a variety of aspects of lipid metabolism. Principally, the liver synthesizes bile, ingredients of which are necessary for fat absorption in the intestine. Moreover, biliary discharge of cholesterol and phospholipids into the intestine is of key significance in body lipid homeostasis. Additionally, the liver supplies the plasma lipoproteins; it produces apoproteins that is responsible for regulating many metabolic interconversions amongst lipoprotein
Cholestasis Treatment Market - Global Industry Analysis 2024
The liver plays a pivotal role in control of a variety of aspects of lipid metabolism. Principally, the liver synthesizes bile, ingredients of which are necessary for fat absorption in the intestine. Moreover, biliary discharge of cholesterol and phospholipids into the intestine is of key significance in body lipid homeostasis. Additionally, the liver supplies the plasma lipoproteins; it produces apoproteins that is responsible for regulating many metabolic interconversions amongst lipoprotein